Investor Relations

News Releases

Date Title and Summary Additional Formats
Toggle Summary Anika to Issue Second Quarter 2021 Financial Results on Thursday, August 5, 2021
BEDFORD, Mass. , July 19, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its second quarter 2021 financial results after the close of the market on Thursday,
View HTML
Toggle Summary First Anika WristMotion® Total Wrist Arthroplasty Surgery Performed
WristMotion Total Wrist Arthroplasty limited launch initiated BEDFORD, Mass. , July 01, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced the limited launch and first surgery performed with
View HTML
Toggle Summary Anika Hosts 2021 Virtual Investor Day
Company details multi-year Joint Preservation strategy for accelerated revenue  growth and profitability Updates 2021 directional outlook and 2024 multi-year targets BEDFORD, Mass. , June 03, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in
View HTML
Toggle Summary Anika to Host its 2021 Virtual Investor Day on June 3, 2021
BEDFORD, Mass. , May 13, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to host its 2021 Virtual Investor Day on Thursday, June 3, 2021 beginning at 9:00am EDT .
View HTML
Toggle Summary Anika Reports First Quarter 2021 Financial Results
Revenue lower by 3% versus pre-COVID in prior year Joint Preservation revenue up 55% as transformative mix shift continues Company on track to achieve stated revenue growth in 2021 BEDFORD, Mass. , May 06, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc.
View HTML
Toggle Summary Anika to Participate in Upcoming Virtual Investor Conferences
BEDFORD, Mass. , May 04, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard , President and Chief Executive Officer and Michael Levitz , Executive Vice President, Chief
View HTML
Toggle Summary Anika to Issue First Quarter 2021 Financial Results on Thursday, May 6, 2021
BEDFORD, Mass. , April 15, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its first quarter 2021 financial results after the close of the market on Thursday, May
View HTML
Toggle Summary Anika to Participate in the 20th Annual Needham Virtual Healthcare Conference
BEDFORD, Mass. , April 05, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard , President and Chief Executive Officer and Michael Levitz , Executive Vice President, Chief
View HTML
Toggle Summary Anika to Participate in the Sidoti Spring Virtual Investor Conference
BEDFORD, Mass. , March 11, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard , President and Chief Executive Officer and Michael Levitz , Executive Vice President, Chief
View HTML
Toggle Summary Anika Reports Fourth Quarter and Year-End 2020 Financial Results
Completed Transformative Year with Q4 2020 Revenue Up 10% Year-Over-Year, Full Year 2020 Revenue up 14% Well Positioned for Growth in 2021 BEDFORD, Mass. , March 04, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company that creates and delivers
View HTML